Insider Transactions in Q2 2025 at Sutro Biopharma, Inc. (STRO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
15,995
-9.05%
|
$0
$0.88 P/Share
|
|
May 15
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
44,719
+8.22%
|
-
|
|
May 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
24,709
-20.23%
|
$24,709
$1.07 P/Share
|
|
May 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
69,063
+22.44%
|
-
|
|
May 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-1.64%
|
$894
$1.07 P/Share
|
|
May 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+4.38%
|
-
|
|
May 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13,538
-10.16%
|
$13,538
$1.07 P/Share
|
|
May 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
37,849
+7.36%
|
-
|
|
Apr 11
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,603
-12.74%
|
$0
$0.6 P/Share
|
|
Apr 11
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+26.26%
|
-
|